M Eric Carter, MD | |
1175 E 50 S Ste 251, American Fork, UT 84003-2850 | |
(801) 492-2815 | |
(801) 492-0191 |
Full Name | M Eric Carter |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 1175 E 50 S Ste 251, American Fork, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1700815834 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 49976621205 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
M Eric Carter, MD 1055 N 500 W, Credentialing Department, Provo, UT 84604-3305 Ph: (801) 354-8225 | M Eric Carter, MD 1175 E 50 S Ste 251, American Fork, UT 84003-2850 Ph: (801) 492-2815 |
News Archive
Cumberland Pharmaceuticals Inc. and Phebra Pty Ltd. today announced that Acetadote® (acetylcysteine) Injection has been granted regulatory approval for marketing and sale in Australia. Acetadote, an injectable drug used to treat acetaminophen (paracetamol) overdose, was approved by the Therapeutic Goods Administration (TGA), the government agency responsible for regulating drugs and medical devices in Australia.
Pennsylvania Department of Health Executive Deputy Secretary Michael Wolf today presented a Commonwealth Universal Research Enhancement Program, or CURE, grant to Carnegie Mellon University. The $983,783 grant will be used for a two-year research project focused on cancer treatment technologies.
Inhibitex, Inc., announced today that Pfizer Inc. presented safety and immunogenicity data from a Phase 1 double-blind randomized placebo controlled study in 408 healthy volunteers of a novel three antigen Staphylococcus aureus investigational vaccine at the 21st European Congress of Clinical Microbiology and Infectious Diseases and 27th International Congress of Chemotherapy in Milan, Italy.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced the execution of a securities purchase agreement with a select group of institutional and accredited investors providing for a private placement, or PIPE financing.
BSD Medical Corporation today announced that it entered into a securities purchase agreement with two institutional investors for the sale of 1,644,737 shares of its common stock in a registered direct offering at $1.52 per share. In addition, warrants to purchase 1,233,553 shares of common stock in the aggregate will be issued to the investors.
› Verified 3 days ago
Wynn H Hemmert, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 36 N 1100 E, Suite A, American Fork, UT 84003 Phone: 801-772-0775 Fax: 801-772-1941 | |
Ms. Yun Ling, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1175 E 50 S, Suite 241, American Fork, UT 84003 Phone: 801-492-5999 Fax: 801-418-0897 | |
Dr. David Allen Bradshaw, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 98 N 1100 E Ste 302, American Fork, UT 84003 Phone: 801-492-2270 | |
Dr. Michael Bryant Jolley, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 170 N 1100 E, American Fork, UT 84003 Phone: 801-357-8310 | |
Nathan Robert Brewster, D.O. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 98 N 1100 E Ste 302, American Fork, UT 84003 Phone: 801-492-2270 | |
Terry C Hammond, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1175 E 50 S Ste 161, American Fork, UT 84003 Phone: 801-377-4623 Fax: 801-377-6832 | |
Von F Welch, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1159 E 200 N, Suite 150, American Fork, UT 84003 Phone: 801-855-2900 |